Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											478.271924326										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C30H38O5/c1-3-4-10-21(2)27(31)16-15-25-26-18-22(17-24(26)19-28(25)32)11-8-9-14-30(34)35-20-29(33)23-12-6-5-7-13-23/h5-7,11-13,15-16,21,24-28,31-32H,8-10,14,17-20H2,1-2H3/b16-15+,22-11-										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=CZUMMMDKQYRZDP-JCAXBLPDSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											2-oxo-2-phenylethyl 5-[(2Z)-5-hydroxy-4-[(1E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]-octahydropentalen-2-ylidene]pentanoate										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											2-oxo-2-phenylethyl 5-[(2Z)-5-hydroxy-4-[(1E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]-hexahydro-1H-pentalen-2-ylidene]pentanoate										
									 
																											
									
																		
										
											SMILES 
										
										
											CC#CCC(C)C(O)\C=C\C1C(O)CC2C\C(CC12)=C\CCCC(=O)OCC(=O)C1=CC=CC=C1										
									 
																		
																		
									
																		
																		
																		
										
											Độ hòa tan
										
										
											Very slightly soluble										
									 
																											
																		
																											
																		
																											
																		
										
											pKa (strongest acidic) 
										
										
											13.72										
									 
																											
																		
										
											pKa (Strongest Basic) 
										
										
											-0.87										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											139.85 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Iloprost is a synthetic analogue of prostacyclin PGI2. Iloprost dilates systemic and pulmonary arterial vascular beds. It also affects platelet aggregation but the relevance of this effect to the treatment of pulmonary hypertension is unknown. The two diastereoisomers of iloprost differ in their potency in dilating blood vessels, with the 4S isomer substantially more potent than the 4R isomer.									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									Iloprost is a synthetic analogue of prostacyclin PGI2. Iloprost dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).								
								
									Iloprost is a second generation structural analog of prostacyclin (PGI) with about ten-fold greater potency than the first generation stable analogs, such as carbaprostacyclin. Iloprost binds with equal affinity to human prostacyclin (Prostanoid IP) and prostaglandin EP1 receptors. Iloprost constricts the ilium and fundus circular smooth muscle as strongly as prostaglandin E2 (PGE2) itself. Iloprost inhibits the ADP, thrombin, and collagen-induced aggregation of human platelets. In whole animals, iloprost acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time. All of these properties help to antagonize the pathological changes that take place in the small pulmonary arteries of patients with pulmonary hypertension.								
							
														
															
								 Dược Động Học  : 
								
									▧ Absorption : 
Rapidly absorbed with bioavailability of 63%
▧ Volume of Distribution : 
* 0.7 to 0.8 L/kg
▧ Protein binding : 
60%
▧ Metabolism : 
Primarily hepatic. Iloprost is metabolized principally via beta-oxidation of the carboxyl side chain.
▧ Half Life : 
20-30 minutes
▧ Clearance : 
* 20 mL/min/kg [Normal subjects]								
	
							 
														
														
								 Độc Tính : 
								
									Overdoses can lead to hypotension, headache, flushing, nausea, vomiting, and diarrhea.									
							
														
							
																					
								 Chỉ Định : 
								
									Used for the treatment of pulmonary arterial hypertension.								
							
	
														
									
							
							
								 Tương Tác Thuốc : 
																
																		
									- 
										Trandolapril
										
											The prostacyclin analogue, Iloprost, may increase the hypotensive effect of Trandolapril.										
									
 								
							
							
							
							
								
								 Liều Lượng & Cách Dùng : 
								
									Solution - Respiratory (inhalation)								
							
	
							
														
														
							
																						
								 Dữ Kiện Thương Mại 
								
																											
										
											Giá thị trường
										
										
											
																							- 
													
													Giá bán buôn : USD >74.4 Đơn vị tính : ml 
- 
													
													Giá bán buôn : USD >74.4 Đơn vị tính : ml 
 
									 
																		
																											
																		
																											
											  
		  
								 
							 	
							
							
														
							
						
							
																													
								 Tài Liệu Tham Khảo Thêm 
								
																		
																		
																		
																		
																		
										
											National Drug Code Directory